Understanding the function of ICOS/ICOSL costimulation in experimental autoimmune myasthenia gravis

DSpace/Manakin Repository

Understanding the function of ICOS/ICOSL costimulation in experimental autoimmune myasthenia gravis

Show full item record


Title: Understanding the function of ICOS/ICOSL costimulation in experimental autoimmune myasthenia gravis
Author: Benjamin Gregory Scott
Abstract: The inducible costimulatory molecule (ICOS) is a relatively new member of the CD28 family of costimulatory molecules. For the first time, we have characterized the role of ICOS/ICOSL costimulation in experimental autoimmune myasthenia gravis (EAMG), a model of human MG. Following acetylcholine receptor (AChR) immunization, ICOS gene-deficient mice were resistant to the development of EAMG due to faulty germinal center formation, decreased levels of anti-AChR IgG of all isotypes tested, and a lack of IgG and complement binding to the neuromuscular junction (NMJ). Compared to control lymphocytes, lymphocytes from AChR-immunized ICOS-deficient mice proliferated poorly and produced significantly less IFN-gamma and IL-10 following in vitro stimulation with AChR or the immunodominant AChR alpha-subunit peptide 146-162. In vivo, the lack of ICOS costimulation led to diminished B cell and plasma cell expansion, whereas the number of CD4+ T helper cells was increased. Collectively, these results indicate that lymphocyte costimulation through the ICOS/ICOSL pathway is a vital component of the adaptive immune response to AChR in EAMG.\r\n
URI: http://hdl.handle.net/2152.3/127
Date: 2005-06-15

Files in this item

Files Size Format View
Dissertation.pdf 4.825Mb PDF View/Open

This item appears in the following Collection(s)

Show full item record

Search DSpace


Advanced Search

Browse

My Account